Very low protein diets supplemented with keto-analogues in ESRD predialysis patients and its effect on vascular stiffness and AVF Maturation

Table 2 Vascular and dialysis initiation characteristics compared in the groups

Characteristics	Study group (28 patients)	Control group (39 patients)	χ² value	SD-value	p-value
Failed AVF creation cases	2 (7.1 %)	5 (12.8 %)	3.11	2.01	0.021
Failed AVF maturation cases	3 (10.7 %)	8 (20.5 %)	2.82	3.19	0.017
AVF diameter (cm) at 4 weeks	0.60 ± 0.09	0.51 ± 0.08	73.396	0.226	<0.001
AVF flow (mL/min) at 4 weeks	698.07 ± 136.13	579.12 ± 105.84	317.2	337.034	0.017
Upper arm AVF (n)	6 (21.4 %)	9 (23.1 %)
AVF diameter (cm) at 3 months	0.70 ± 0.07	0.67 ± 0.08	84.35	0.191	<0.001
AVF flow (mL/min) at 3 months	756.92 ± 136.62	722.65 ± 122.25	364	338.25	0.007
Maturation time (weeks)	5.91 ± 0.92	7.15 ± 1.19	34.45	2.775	<0.001
Dialysis initiation (%)	11 (39.3 %)	19 (48.7 %)	6.31	5.61	0.5
CVC-HD initiation (%)	2 (7.1 %)	5 (12.8 %)	4.5	2.121	0.5

AVF arteriovenous fistula, CVC-HD initiation hemodialysis initiation on central venous catheter, χ² value > χ² critical value, statistically significant, p-value < α-value = 0.05, statistically significant

ISSN: 1471-2369